Found 1202 All Conditions trials
A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
This research study is being conducted to assess the safety and efficacy of IPH4102, an investigative medication (medication not approved by the Food and Drug Administration (FDA) for subjects diagnosed with Sézary Syndrome (SS) or Mycosis Fungoides (MF) over the age of 18. Participants will be asked to complete the …
This study is a prospective, multi-center will enroll up to 500 participants (in approximately a 2:1 ratio) who are undergoing implantation of a CIED with either a CanGaroo envelope or no envelope. The CanGaroo Envelope is designed to absorb over time, releasing its intrinsic biologic signals which trigger site-specific tissue …
The purpose of this study is to compare the effects of the study drug versus a placebo on reducing the number of septal reduction therapy procedures performed in patients with symptomatic oHCM.
The purpose of this trial is to determine whether Phasix™ Mesh helps prevent incisional hernias that sometimes occur after abdominal surgery by strengthening the closure of the tissue and/or the incision following surgery.
This research study is being conducted to examine the effects of electronic cigarette aerosol, in the presence and absence of nicotine, on the endothelium, a layer of cells that act as a protective barrier and play an important part in controlling the flow of blood around the body.
The purpose of this study is to see if an investigational vaccine for cytomegalovirus (CMV), called Triplex®, is safe when given to people with both Human Immunodeficiency Virus (HIV) and CMV.
The research study is being conducted to assess the safety and efficacy of Medtronic’s Next Generation ICD lead. Duration 18 to 36 months.
The purpose of Part A of this study is to evaluate the safety, tolerability, and cardiac pharmacodynamics (the effect of the study drug on your heart) of the study drug, danicamtiv, when administered by mouth twice a day for approximately one to two weeks. Part A which may last between …
The purpose of this research study is to learn about the safety and effectiveness of the study drug called pitolisant when compared with placebo (a tablet that does not contain any study drug) in treating some of the symptoms of Myotonic Dystrophy Type 1, such as excessive daytime sleepiness.
This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.
